Predict your next investment

Corporation
HEALTHCARE | Medical Devices & Equipment / Therapeutic Devices
prometheuslabs.com

See what CB Insights has to offer

Founded Year

1995

Stage

Acquired - II | Acquired

Total Raised

$392.8M

About Prometheus Laboratories

Prometheus Laboratories develops products focused on the treatment, diagnosis, and detection of gastrointestinal, autoimmune, and inflammatory diseases and disorders.

Prometheus Laboratories Headquarter Location

9410 Carroll Park Drive

San Diego, California, 92121,

United States

858-824-0895

Latest Prometheus Laboratories News

Prometheus’ Agreement with MultiPlan Expands Patient Access to Specialized GI Testing

Jun 18, 2021

Prometheus Laboratories, Inc. , San Diego, announced an agreement with  MultiPlan , New York, N.Y., a partner to more than 700 healthcare payors. The agreement will provide access to all Prometheus testing services to over 60 million members and one million healthcare providers in MultiPlan’s provider networks. Prometheus offers breakthrough testing solutions that help optimize care and improve outcomes in GI diseases and disorders. “Access to our specialized testing services through the partnership with MultiPlan, its partners, providers, and plan members will significantly expand the availability of these important services to help transform patient care,” says Mike Walther, president of Prometheus Laboratories. Share:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Prometheus Laboratories Patents

Prometheus Laboratories has filed 10 patents.

The 3 most popular patent topics include:

  • Autoimmune diseases
  • Clusters of differentiation
  • Inflammations
patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/24/2018

11/2/2021

Autoimmune diseases, Monoclonal antibodies, Rare diseases, Inflammations, Clusters of differentiation

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

8/24/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

11/2/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Autoimmune diseases, Monoclonal antibodies, Rare diseases, Inflammations, Clusters of differentiation

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.